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INTRODUCTION  
Brain tumours are among the common neoplasms of humans. 
Patients tend to concentrate in institutions where diagnostic and the 
therapeutic services are available. The incidence of brain tumors is around 
4 per 1,00,000 population. Supratentorial brain tumours constitute about 
80% of brain tumours in adults and 40% of tumours in paediatric 
population. Brain neoplasms are found in 2% of autopsy series and account 
for 1% of all the hospital admissions1.  
Diagnosis of brain tumours may be delayed as the initial symptoms 
and signs are vague and nonspecific. The symptoms include headache, 
focal seizures and focal neurological deficit, with clinical examination 
revealing, raised intracranial tension or focal neurological deficit. 
Therefore the clinicians rely heavily on imaging for an early and 
accurate diagnosis. Significant advance has been made during the last two 
decades in radiological diagnosis and characterization of brain neoplasms. 
The goals of diagnostic imaging in the patient with suspected 
intracranial tumor include detection of the presence of a neoplasm, 
localization of the extent of the tumor (including definition of involvement 
of key structures and assessment of the presence and severity of secondary 
changes, e.g., edema, herniation, hemorrhage), and characterization of the 
nature of the process.This  has been made possible by modern imaging 
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modalities like CT and MRI and refinements of previous technique such as 
angiography. In addition stereotactic biopsy under imaging guidance 
permits histological diagnosis of brain neoplasm2. 
Both CT and MRI provide excellent anatomic details and information 
regarding the presence, location and extent of brain tumours. 
COMPUTED TOMOGRAPHY: 
CT has the capacity to differentiate a wide range of tissue types 
including air, fat, soft tissue and bone with superior spatial resolution. The 
use of iodinated contrast agents allow better delineation of vascular 
anatomy and pathological entities, and can differentiate enhancing lesion 
from surrounding reactive change. CT is highly sensitive to calcification and 
blood within the brain parenchyma. CT is preferred for the uncooperative 
and unstable patients, because each axial image is obtained separately. 
Thus, motion artifact is minimized, particularly in later generation scanners 
which can perform individual scans in less than 2 seconds. 
CT characterization provides a better insight to the nature of lesion 
and its effect on the adjacent structures. It also provides a road map for the 
neurosurgeon regarding the approach, likely duration of surgery, 
requirements for anaesthesia etc. 
Upgradation in recent CT technologies like helical mode helps in 3 
dimensional visualization of the neoplasm. 
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Wider experience in CT and familiarity of the lesions in CT favor CT 
as an important and appropriate investigation tool. 
MAGNETIC RESONANCE IMAGING: 
MRI has rapidly earned recognition as the optimal screening 
technique for the detection of most intracranial neoplasms. Compared with 
CT, MRI using spin echo, gradient echo, and combination spin and gradient 
echo pulsing sequences before and after intravenous (IV) administration of 
paramagnetic contrast agents provides inherently greater contrast resolution 
between structural abnormalities and adjacent brain parenchyma and has 
proved to be even more sensitive in the detection of focal lesions of the 
brain. Early experience suggested that upto 30% more focal intracranial 
lesions could be identified on MRI than on CT3,4. 
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AIMS OF THE STUDY 
To assess the role of computed tomography, magnetic resonance 
imaging in 
1) Detection & localization of primary brain tumours. 
2) Characterisation of lesions, assessing extent and mass effect of 
lesions. 
3) Giving specific diagnosis of the tumours using characteristics 
shown by  CT and MRI. 
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REVIEW OF LITERATURE 
HISTORY: 
Within years after Wilhelm C. Roentgen announced the discovery of 
x-rays in 1895, Church reported the first use of x-rays to localize a brain 
tumour, a densely calcified cerebellar tumour. It soon became evident, 
however, that a non calcified lesion would be virtually indistinguishable by 
plain film alone. 
The introduction of air ventriculography and pneumo 
encephalography by Walter Dandy in 1918 made it possible to deduce by 
indirect means the presence and size of intracranial masses by their 
compressive effect on the air filled ventricular system. 
In 1927, Egas Moniz introduced cerebral angiography in which 
iodinated positive contrast was instilled into the intracranial arterial system; 
This allows for a more accurate diagnosis of intracranial masses by analysis 
of displacement of cerebral vessels. 
For more than 50 years, pneumoencephalography and cerebral 
angiography were the only modalities for neuroradiological diagnosis of 
brain tumours. 
With the advent of computer tomography in 1972 by Hounsfield, a 
British Physicist, cross sectional imaging techniques have since replaced 
these techniques for the evaluation of intracranial mass lesion. The original 
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EMI scanner was designed specifically for evaluation of the brain. In this 
unit the head was enclosed in a water bath between the x-ray to be above 
and a pair of detectors below. 
One major objective of the later second and third generation 
scanners was to shorten the scanning time for each tomographic section. 
Recently developed CT technology, spiral CT permits rapid volume 
data acquisition and reconstruction of the image in any plane. These 
techniques are faster than conventional CT and so there is less likelihood of 
motion artifacts. 
The phenomenon of Magnetic resonance was described 
independently but almost simultaneously by Bloch and Purcell and their 
colleagues in 1946.Human in vivo images were first published in 1977 by 
Mansfield & Maudsley, Damadian et al and Hinshaw et al. Hawkes et al in 
1980 demonstrated the multiplanar facility of MRI and reported the first 
demonstration of intra cranial pathology using MR. 
DIAGNOSTIC IMAGING 
Computed Tomography (CT) 
Before the introduction of computed tomography (CT) in the early 
l970s, confirmation of the presence or absence of brain tumor involved the 
use of invasive diagnostic procedures (e.g., cerebral angiography or 
pneumoencephalography) that required hospitalization and carried some 
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morbidity and risk. Clinicians were often reluctant to submit patients with 
uncertain history and findings to such risks. 
The advent of CT significantly altered the method and timing of 
diagnostic evaluation of the patient with suspected brain tumor.5,  6  CT 
evaluation of the brain is relatively noninvasive and is therefore easily and 
rapidly accomplished. In the mid-1970s, CT emerged as the primary 
diagnostic screening modality for the detection of intracranial disease. 
Areas of structural abnormality (e.g., tumors) appeared on CT as regions of 
altered tissue radiographic density. Accuracy of localization with CT 
exceeded the accuracy that could be achieved by cerebral angiography or 
other invasive diagnostic procedures. Another important advantage of CT 
was the demonstration of no disease in the symptomatic patient who did 
not have a neoplasm or other structural abnormality, thus affording 
reassurance to the patient and physician and avoiding costly hospitalization 
and more invasive or more hazardous diagnostic procedures.7 Conversely, 
CT occasionally revealed abnormalities (including tumors) that were not 
suspected clinically in patients with relatively nonspecific complaints. 
Magnetic Resonance Imaging (MRI) 
Lesions and tissues with increased water content appear even more 
conspicuous on T2-weighted MR images than on CT images obtained after 
IV infusion of contrast agents8. Delineation by MRI of normal and abnormal 
soft tissue anatomy in the posterior cranial fossa, near the base of the skull, 
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and in other areas of the brain that lie adjacent to dense bone is 
considerably better than with CT because of MRI’s lack of the beam 
hardening artifacts secondary to absorption of x-rays in bone seen on CT. 
Accuracy of lesion localization on MRI is enhanced by its direct multiplanar 
capability, which permits acquisition of images in the coronal and sagittal 
plane in addition to the axial plane conventionally used in CT. MRI offers 
superior contrast resolution, including greater sensitivity for the detection of 
subacute and chronic hemorrhage in association with tumors and other 
structural lesions of the brain. 
The ability with MRI (using conventional anatomic imaging protocols 
as well as MRI angiography sequences that display blood flow) to visualize 
vessels supplying and draining structural lesions in the brain adds yet 
another important dimension of information that can contribute to the 
diagnostic assessment. 
Even with current state of the art equipment utilizing very high 
magnetic fields and rapidly switching gradient coils, MR nevertheless suffers 
two disadvantages in comparison with CT in the assessment of intracranial 
structural abnormalities. 1.MRI requires significantly longer  acquisition 
times and 2. Abnormalities involving cortical bone, intratumoral 
calcification, and hyperacute hemorrhage are more clearly and accurately 
assessed with CT. Newer multi-slice helical or spiral CT scanners are 
capable of providing highly collimated submillimeter thickness sectional 
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images in extremely short acquisition times, and thus areas of hyperostosis 
or bone destruction, intratumoral calcifications, and early intratumoral or 
peritumoral hemorrhage are more completely defined with greater certainty 
on CT than on MRI. The much faster acquisition capability of current CT 
units strongly favors their use in patients who are critically ill or medically 
unstable. Also, in patients with magnetically controlled cardiac pacemakers 
and other internal paramagnetic metallic devices, the risk of the MRI 
magnet interacting with such devices may preclude the use of MRI. 
Given both the higher cost and more restricted availability of MR 
equipment to date as well as continuing improvements in CT equipment 
and scanning techniques that permit shorter examination times with 
improved spatial and contrast resolution, it is not surprising that CT 
remains a major imaging technique for the follow up of intracranial mass 
lesions. In current clinical practice initial diagnosis and localization of brain 
lesions are most often accomplished with MRI, but the imaging modality of 
convenience for followup studies is often CT. 
Multiplanar MRI also increases the diagnostic precision with which 
paraventricular masses can be differentiated from intraventricular masses. 
Paraventricular tumour characteristic all displace the choroid plexus and 
compress the lateral ventricles, whereas intraventricular masses cause local 
ventricular expansion and, generally conform to the shape of the ventricle. 
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Imaging (usually magnetic resonance imaging (MRI) is extensively 
utilized in treatment planning before surgery or radiation to define the gross 
tumour margins and to  permit selection of the safest approach to the 
lesion. 
Functional MRI is increasingly employed preoperatively to determine 
the location of functionally eloquent cortex, which can then be avoided 
during an operative approach. Interactive computerized neuronavigational 
devices utilize these data (1) to allow administration of very high doses of 
precisely focused radiation to small (up to 3 cm) intracranial tumors while 
sparing the adjacent normal brain and (2) to accurately register the 
previously acquired image data set onto intraoperative space, thus enabling 
precise intraoperative localization of surgical instrumentation relative to 
tumor margins, key vascular structures, and other critical anatomy. A 
relatively new and highly promising application is image guided surgery, in 
which the entire surgical resection is guided by direct real time MRI in the 
operating room environment. 
Follow up assessment of intracranial neoplasms utilizes CT and MRI 
and related techniques extensively, including MRI spectroscopy and MRI 
perfusion weighted imaging, to monitor post-treatment complications and 
to detect the presence of residual or recurrent tumor. 
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NEWER DIAGNOSTIC TECHNIQUES: 
Accumulated experience together with continuing improvements in 
contrast discrimination and spatial resolution have permitted highly 
accurate correlation between CT and MRI appearance and histologic 
grading of supratentorial gliomas. However noninvasive differentiation 
between high grade glioma with a cystic or necrotic center, solitary 
metastatic carcinoma with central necrosis, resolving hematoma, resolving 
infarction, atypical mass like presentation of a tumefactive multiple sclerosis 
plaque, and cerebral abscess on the basis of CT or MRI findings remains a 
difficult task. Also, precise and accurate separation of infiltrating high grade 
glioma from surrounding edema is not currently attainable with either 
conventional MRI or CT, even after IV administration of contrast medium. 
Differentiation between recurrent tumor and radiation necrosis is another 
major diagnostic problem in the management of the patient with malignant 
glioma who has already undergone surgical resection with postoperative 
radiation therapy. Newer diagnostic techniques based on magnetic 
resonance are addressing these problems. 
Magnetic Resonance Spectroscopy (MRS) 
In magnetic resonance spectroscopy (MRS), the resonance signal that 
is utilized to generate an image in MRI is instead used to generate a 
frequency spectrum reflecting the components that make up that image9. In 
normal brain tissue, these components reflect both the water content of the 
brain and the metabolism of the normal neurons and glial cells. If the signal 
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from water is suppressed, the frequency spectrum (expressed in parts per 
million [ppm]) reflects the cellular metabolism of the brain in the voxel or 
section of tissue being interrogated. 
The highest- peak amplitude in the normal brain frequency spectrum 
is that of N-acetyl aspartate (NAA), which occurs at a frequency of 2.0 ppm. 
NAA is a specific marker of neuronal density and viability. The next highest 
peak in the normal brain spectrum is that of creatine (Cr), at 3.03 ppm; 
creatine is involved in energy dependent processes of cellular metabolism in 
many different types of cells. The third highest peak of the normal brain 
spectrum is that of choline (Cho), which is involved in and reflects the 
metabolism of cellular membrane turnover; its frequency peak is 3.2 ppm. 
In normal brain, the ratio of the height of the choline peak to that of the 
creatine peak (Cho/Cr) is less than 1.0. 
Another important metabolite peak occurs at approximately 1.32 
ppm and reflects both lipids and lactate. Lactate is not a normal constituent 
of brain metabolism; its presence indicates that the normal cellular 
oxidative metabolism has been altered and that glycolysis is taking place via 
anaerobic pathways. An elevated lactate peak is seen in the presence of 
cellular necrosis and reflects lesions that have outgrown their blood supply- 
for example, the central portions of abscesses, malignant gliomas, 
lymphomas, and carcinomatous metastases. Lipids resonate at a similar 
frequency and are also found in highly malignant tumors. 
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When the interrogating voxel is placed on the peripheral contrast 
enhancing rim of a rounded intracerebral mass with central hypointensity 
on TI -weighted MRI, the MR spectroscopic pattern demonstrating elevation 
of the choline peak with depression of the NAA and creatine peaks is 
typical for both primary and secondary malignant tumors of the brain and 
does not aid in their differentiation. MRS of the central hypointense  region 
of such a mass demonstrates elevated lactate and lipid signals, which 
indicate only the presence of necrosis and do not provide differential 
information. However, the choline peak in peripheral viable tissue is not 
elevated in inflammatory processes such as fungal, parasitic, and bacterial 
abscesses, possibly representing an important differential finding10. 
It is clearly established that in malignant gliomas, infiltrating tumor 
cells are present well beyond, the contrast enhancing tumor margins seen 
on CT scans and MR images. However, in metastasis, the peritumoral 
region contains no infiltrating tumor cells. Studies involving MR 
spectroscopic interrogation of the peritumoral region in patients with 
solitary brain tumors have document elevated choline levels with reversal of 
the normal Cho/Cr ratio in the peritumoral region in patients who have 
infiltrating high grade gliomas but not in patients who have metastases11. 
This finding on MRS may enable the discrimination between malignant 
glioma and metastasis and suggests that the peritumoral hyperintensity on  
T2-weighted images and the peritumoral hypointensity on T1- weighted 
images seen in association with malignant gliomas may reflect not only 
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vasogenic edema but also tumor infiltration, whereas the lack of reversal of 
the normal Cho/Cr ratio in the peritumoral tissue surrounding metastases 
suggests that the similar MRI appearance of this tissue is likely due to 
edema or gliosis. 
PERFUSION-WEIGHTED MRI 
Another difference between patients with malignant glioma and those 
with metastasis has been noted on dynamic contrast enhanced perfusion-
weighted MRI utilizing a first pass image acquisition protocol after bolus IV 
administration of gadolinium12. One Study has demonstrated a significant 
increase in relative cerebral volume (rCBV) in the peritumoral region in 
patients with malignant gliomas, and a diminished rCBV in the peritumoral 
region in patients with metastases. Increased peritumoral perfusion in 
patients with malignant gliomas is presumed to be due to tumor infiltration 
into the peritumoral region with associated loss of blood-brain barrier 
integrity. Diminished peritumoral perfusion in the tissue surrounding a 
metastasis may reflect an intact blood-brain barrier with the vasogenic 
edema causing local compression of the microcirculation. 
POSITRON EMISSION TOMOGRAPHY 
Studies of cerebral oxygen metabolism using the positron-emitting 
isotope fluorine- 18 tagged 2 fluoro deoxyglucose (FDG), an analogue of 
glucose, have established that most malignant brain tumors have increased 
glucose uptake and metabolism compared with normal brain parenchyma, 
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that the level of FDG uptake correlates well with histologic grade in cerebral 
gliomas, and that FDG positron emission tomography (PET) is a good 
predictor of prognosis in these tumors13. 
Differentiation between recurrent tumor and radiation necrosis 
remains a major unsolved problem in the management of patients with 
malignant gliomas. Both processes can present the heterogeneous 
appearance of a growing infiltrative mass with irregularly marginated 
contrast enhancement on CT and MRI. Early work suggested that necrotic 
tissue failed to take up the radioactivity and appeared hypometabolic and 
that actively growing tumor demonstrated strong hypermetabolic uptake.  
This finding was verified on a subsequent study demonstrating high 
sensitivity and specificity for FDG PET. However, other studies have 
questioned the accuracy and specificity, and therefore the utility, of FDG 
PET for this indication. 
CLASSIFICATION OF PRIMARY BRAIN TUMOURS 
Bailey & Cushing in 1926 were the first to propose classifications of 
brain tumours based on the cell of origin, subsequently developed by 
Russel and Rubinstein in 1989, WHO subsequently devised a modification to 
Russel and Rubinstein classification in 1994 thus giving an impetus and 
standardization of Brain tumours. Neurons and neural glialcells are the two 
tissues that make up the central nervous system. Neuroglia consist of 
Astrocyte,Oligodendrocyte, microglia, ependyma and choroid epithelium. 
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Vast majority of brain tumours arise from the neuroglia and are included 
under a broad term gliomas. Added to the list of primary tumours are 
tumours arising from the pineal Body, meningiomas, germ cell tumours, 
and lymphoma. Dermoid, epidermoid, arachnoid cyst and colloid cyst are 
considered to be maldevelopmental in origin. Metastatic tumours represent 
secondary malignancies of the brain and its coverings. 
The current International Histological classification of CNS tumours 
drafted in 2000 revision by the World Health Organisation is as follows14. 
This classification has been adapted and modified from Kleihues P, 
Cavenee WK (eds): Pathology and genetics of the tumours of the nervous 
system. Lyon, international agency for research on cancer ,2000. 
GLIAL TUMOURS 
Astrocytomas 
Circumscribed Astrocytomas 
Juvenile Pilocytic Astrocytoma 
Pleomorphic Xanthoastrocytoma 
Subependymal giant cell astrocytoma 
 Diffuse Astrocytomas 
 Low grade astrocytomas 
  Optic pathway Glioma 
  Brain stem Glioma 
 Anaplastic Atrocytoma 
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Glioblastoma Multiforme  
Gliomatosis Cerebri 
 Gliosarcoma 
Oligodendroglioma 
Low Grade Oligodendroglioma 
Anaplatsic Oligodendroglioma 
Ependymomas  
          Ependymoma 
          Subependymoma 
Choroid plexus tumours  
          Choroid plexus papilloma 
          Choroid plexus carcinoma 
NONGLIAL TUMOURS 
Neuronal and mixed  
Neuronal / glial tumours 
        Ganglioglioma 
        Gangliocytoma  
         Lehermitte – Duclos disease 
                   Desmoplastic infantile ganglioglioma 
                    Dysembryoplastic Neuro Epithelial Tumour 
                    Central neurocytoma 
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 Pineal Parenchymal tumours 
  Pineoblastoma 
  Pineocytoma 
Embryonal tumours  
Medulloblastoma 
  Supratentorial primitive neuroectodermal tumours 
TUMOURS OF THE CRANIAL NERVES 
Schwannoma 
Neurofibroma 
Malignant Peripheral nerve sheath tumours 
TUMOURS OF THE MENINGES 
Meningioma 
Hemangiopericytoma 
Mesenchymal non meningothelial tumours 
Melanocytic tumours 
Hemangioblastoma 
TUMOUR OF THE HEMOPOIETIC SYSTEM 
Primary CNS Lymphoma  
Secondary CNS Lymphoma 
Histiocytic lesions  
Granulocytic sarcoma 
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GERMCELL TUMOURS 
Germinoma 
Teratoma 
Other germ cell tumours 
TUMOURS OF THE SELLAR REGION 
Pituitary adenoma  
  Miroadenoma  
 Macroadenoma 
Craniopharyngioma 
Rathke cleft cyst 
Tumours Of The Neuro Hypophysis 
Chordoma 
METASTATIC TUMOURS 
Metastases to the brain 
Metastases to the skull and intracranial dura 
Leptomeningeal Metastasis (leptomeningeal carcinomatosis) 
CHARACTERISTICS OF PRIMARY BRAIN TUMOURS 
Location: 
Tumour location is important for differential diagnosis of brain 
neoplasms and for determining imaging technique. Coronal plane imaging 
of the sella is an example of adjusting imaging technique for tumour 
location15. 
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Extra axial location are typical of Benign intracranial neoplasm and 
parenchymal infiltration is characteristic of malignant brain tumours. On 
imaging extra axial masses buckles the white matter, expands the ipsilateral 
subarachnoid spaces, and sometimes causes reactive bone changes. An 
intraxial mass expands the cortex of the brain, separation of the lesion from 
the underlying leptomeninges is not seen, lesion spreads across well defined 
boundaries, and the dura is seen peripheral to the mass. 
List of differential diagnosis of common supratentorial primary Brain 
tumours in relation to the anatomical location. 
I. Cerebral Hemispheres 
Astrocytoma 
GBM   
Oligodendroglioma 
Meningioma 
II. Leptomeninges & Dura 
Meningioma 
Metastasis 
Lymphoma 
Leukemia 
III. Deep structure (periventricular, thalamus and basal ganglia) 
Primary Cerebral lymphoma 
Primary Cerebral neuroblastoma 
Glioma – often High grade 
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IV. Corpus Callosum 
GBM 
Lymphoma 
Metastasis 
Lipoma (in Corpus Callosal Agenesis) 
V. Lateral ventricle 
Ependymoma 
Meningioma 
Choriod plexus Papilloma 
Primary cerebral neuroblastoma 
Subependymoma 
VI. Foramen of Monro 
Giant cell astrocytoma 
Colloid cyst 
Ependymoma 
Subependymoma 
VII. Third Ventricle 
Colloid cyst 
Ependymoma 
VIII. Optic chiasma region 
Pilocytic astrocytoma 
Craniopharyngioma 
Meningioma 
Germinoma 
Arachnoid cyst 
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IX. Pituitary region 
Adenoma 
Craniopharyngioma 
Meningioma 
Dermoid tumour 
Rathke Cleft cyst 
X. Pineal region 
Germinoma 
Teratoma 
Pineocytoma 
Glioma 
INFRATENTORIAL LESIONS 
ADULT 
  Metastases 
  Hemangioblastoma 
Acoustic schwannoma 
Meningioma  
Epidermoid 
Other schwannomas  
Vascular lesions 
Paragangliomas 
CHILDREN 
  Medulloblastoma 
  Cerebellar astrocytoma 
  Brainstem glioma 
Ependymoma and choroids plexus papilloma 
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MARGINS: 
Smooth, sharply defined margins favor the diagnosis of benign 
lesion, and irregular, poorly defined margins favor malignant neoplasms, 
due to their tendency for parenchymal infiltration. 
PARENCHYMA: 
Heterogenicity in a tumour are due to Hemorrhage, calcification, fat, 
cyst formation and necrosis. 
CT & MRI CHARACTERISTICS OF COMMON PRIMARY NEOPLASMS16  
1. DIFFUSE ASTROCYTOMA, LOW GRADE 
CT Findings 
NECT 
• Illdefined homogeneous hypodense/isodense mass 
• 20% Ca++; cysts are rare 
• Calvarial erosion in cortical masses (rare) 
CECT 
• No enhancement or very minimal 
• Enhancement should raise suspicion of focal malignant 
degeneration 
MR findings 
• T1WI 
¾ Homogeneous hypointense mass 
¾ May expand white matter and adjacent cortex 
¾ Appears circumscribed, but infiltrates adjacent brain 
¾ Hemorrhage or surrounding edema (rare) 
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• T2WI 
¾ Homogeneous hyperintense mass 
¾ May appear circumscribed, but often infiltrates adjacent brain 
• FLAIR: Homogeneous hyperintense mass 
• DWI: Restricted diffusion usually absent 
• T1 C+  : 
¾ Usually no enhancement 
¾ Enhancement suggests progression to higher grade 
• MRS 
¾ High choline, low NAA typical but not specific 
2. ANAPLASTIC ASTROCYTOMA 
CT Findings 
NECT 
• Low density ill-defined mass 
• Ca++ and hemorrhage rare 
CECT 
• Majority do not enhance 
• Enhancement often focal, patchy, heterogeneous 
MR findings 
• T1WI 
¾ Mixed isointense to hypointense WM mass 
¾ Ca++, hemorrhage, cysts rare 
30 
• T2WI 
¾ Heterogeneously hyperintense 
¾ May appear discrete, but infiltrates adjacent brain 
¾ May involve and expand overlying cortex 
¾ Ca++, hemorrhage, cysts are rare 
• FLAIR: Heterogeneously hyperintense  
• DWI: No diffusion restriction is typical 
• T1 C+ : 
¾ Usually no enhancement 
¾ Less common: focal, nodular, homogeneous, patchy 
enhancement 
3. GLIOBLASTOMA MULTIFORME 
CT Findings 
NECT 
• Irregular isodense or hypodense mass with central hypodensity 
representing necrosis 
• Marked mass effect and surrounding edema/tumour infiltration 
• Hemorrhage not uncommon 
• Ca++ rare (related to low grade tumor degeneration) 
CECT:          95% have strong, heterogeneous, irregular rim-enhancement. 
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MR findings 
• T1WI 
¾ Irregular isointense, hypointense white matter mass 
¾ Necrosis, cysts and thick irregular margin common may have 
sub acute hemorrhage.  
T2WI : 
¾ Hetegeneous, hyperintense mass with adjacent tumor 
infiltration/ vasogenenic edema. 
¾ Viable tumor extends far beyond signal changes 
Necrosis, cysts, hemorrhage, fluid/debris levels, flow voids 
(neovascularity) may be seen 
¾ FLAIR: Heterogeneous, hyperintense mass 
• DWI :  
¾ Lower measured ADC than low grade gliomas 
• T1 C+ : 
¾ Thick, irregular rind of enhancement surrounding central 
necrosis typical 
¾ Enhancement may be solid, ring, nodular or patchy 
4. PILOCYTIC ASTROCYTOMA 
CT Findings 
NECT 
• Discrete cystic/solid mass 
• May have little or no surrounding edema 
• Ca++, 20%, hemorrhage rare 
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CECT 
• >95% enhance (pattern vary) 
• 50% nonenhancing cyst, strongly enhancing mural nodule. 
MR findings 
• T1WI 
¾ Solid portion iso/hypointense to GM 
¾ Cyst contents iso-to slightly hyperintense to CSF 
• T2WI 
¾ Solid portions hyperintense to GM 
¾ Cyst contents hyperintense to CSF 
• FLAIR: 
¾ Solid portions hyperintense to GM 
¾ Cyst contents do not suppress: Hyperintense to CSF 
• T1 C+: 
¾ Intense but heterogeneous enhancement of solid portion 
¾ Cyst wall occasionally enhances 
5. PLEOMORPHIC XANTHOASTROCYTOMA 
CT Findings 
NECT 
• Cystic/Solid mass: Hypodense with mixed density nodule 
• Minimal or no edema is typical 
• Ca++, hemorrhage, frank skull erosion rare 
CECT: Strong, sometimes heterogeneous enhancement of tumor nodule. 
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MR findings 
• T1WI 
¾ Mass is hypointense or isointense to gray matter 
¾ Mixed signal intensity may be seen 
¾ Cystic portion isointense to CSF 
• T2WI 
¾ Hyperintense or mixed signal intensity mass 
¾ Cystic portion isointense to CSF 
• FLAIR: Hyperintense or mixed signal intensity mass 
• Cystic portion isointense to CSF 
• T1 C+  : 
¾ Enhancement usually moderate/strong, well-delineated 
¾ Enhancement of adjacent meninges, dural “tail” common 
approximately 70 %. 
¾ Enhancing nodule often abuts pial surface 
6. SUBEPENDYMAL GIANT CELL ASTROCYTOMA 
CT Findings 
NECT 
• Hypodense Æ Isodense 
• Ca++ variable 
• Hydrocephalus 
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CECT 
• Heterogeneous, strong enhancement 
• Initially tumor typically >1cm 
MR findings 
• T1WI 
¾ Hypointense to isointense to GM 
¾ +Ca++ (hyperintense to hypointense) 
• T2WI 
¾ Heterogeneous 
• FLAIR: Heterogeneous hyperintense 
• Periventricular interstitial edema from ventricular obstruction 
7. OLIGODENDROGLIOMA 
CT Findings 
NECT 
• Mixed density(hypodense/isodense) hemispheric mass that 
extends to cortex. 
• Majority calcify, nodular or clumped Ca++ (70-90%) 
• Cystic degeneration common (20%) 
CECT 
• Approximately 50% enhance 
• Enhancement varies from none to striking 
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MR findings 
• T1WI 
¾ Hemispheric mass, hypointense to isointense to GM 
¾ Typically heterogeneous 
¾ Cortical and subcortical with cortical expansion 
• T2WI 
¾ Typically heterogeneous, hyperintense mass 
¾ Heterogeneity related to Ca++, cystic change, blood products 
• Typically expands overlying cortex 
• FLAIR 
¾ Typically heterogeneous, hyperintense 
• DWI: No diffusion restriction is typical 
• T1 C+ : 
¾ Heterogeneous enhancement is typical 
8. EPENDYMOMA 
CT Findings 
NECT 
• Infratentorial 
• 4th ventricular tumour extends into CPA/Cisterna magna 
• Ca++ common (50%); +/- cysts, hemorrhage 
• Supratentorial 
• Large heterogeneous periventricular mass 
• CA++ common (50%) 
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CECT:     Variable heterogeneous enhancement 
MR findings 
• T1WI 
¾ Heterogeneous, usually iso-to hypointense 
• T2WI 
¾ Heterogeneous, usually iso-to hyperintense 
• FLAIR 
¾ Can show sharp interface between tumour and CSF 
¾ T1 C+: Mild to moderate, hetetogeneous enhancement 
9. SUBEPENDYMOMA 
CT Findings 
NECT 
• Isodense to hypodense intraventricular mass 
• Cysts or Ca++ may be seen in larger lesions. 
CECT 
• No enhancement, mild enhancement typical 
MR findings 
• T1WI 
¾ Intraventricular mass, hypointense or isointense to white 
matter 
¾ Typically homogeneous solid mass 
• T2WI 
¾ Hyperintense intraventricular mass 
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• FLAIR:    Hyperintense intraventricular mass 
• T1 C+: Variable enhancement, typical none to mild 
10. CHOROID PLEXUS PAPILLOMA 
CT Findings 
NECT 
• Intraventricular bosselated mass 
• 75% iso-or hyperattenuating 
• Ca++ in 25%, hydrocephalus 
CECT 
• Intense, homogeneous enhancement 
• Heterogeneous enhancement suggests choroid plexus 
carcinoma (CPCA) 
MR findings 
• T1WI 
¾ Well delineated, lobulated mass 
¾ Iso-to hypointense 
• T2WI 
¾ Iso-to hyperintense 
• FLAIR: Bright periventricular signal 
• T1 C+ : Robust homogeneous enhancement 
• MRA: Flow related signal within mass 
• Enlarged choroidal artery (trigonal mass) 
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11. DYSEMBRYOPLASTIC NEURO EPITHELIAL TUMOUR-DNET 
CT Findings 
NECT 
• Wedge-shaped low density area 
• Cortical / subcortical lesion 
• Scalloped inner table in 44-60%. 
CECT 
• Usually nonenhancing 
MR findings 
• T1WI 
¾ Pseudocystic, multinodular (“bubbly”) mass 
¾ Hypointense on T1  
• T2WI 
¾ Very hyperintense on T2 
• FLAIR: Mixed (hypo/isointense) signal with “bright” rim. 
• DWI: Usually lacks restricted diffusion 
• T1 C+:   Usually does not enhance 
12. CENTRAL NEUROCYTOMA 
CT Findings 
NECT 
• Usually mixed solid and cystic (Isodense/hyperdense) 
• Ca++ common, 50-70% 
• Hydrocephalus common 
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CECT:  Moderate, heterogeneous enhancement 
MR findings 
• T1WI 
¾ Heterogeneous, mostly isointense to gray matter cysts are 
hypointense. 
• T2WI 
¾ Heterogeneous, hyperintense “bubbly” appearance 
• FLAIR:     Heterogenous, predominantly hyperintense mass 
• T1 C+:  Moderate to strong heterogeneous enhancement 
13. PINEOBLASTOMA 
Imaging Findings 
• Large, heterogeneous pineal mass with “exploded”, peripheral 
Ca++ 
• Nearly 100% with obstructive hydrocephalus 
14.PINEOCYTOMA 
Imaging Findings 
• Enhancing, circumscribed pineal mass which “explodes” 
pineal ca++ 
• May mimic pineal cyst or pineoblastoma 
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15. MEDULLOBLASTOMA (PNET-MB) 
CT Findings 
NECT 
• Solid mass in 4th ventricle 
• 90% hyperdense 
• Ca++ in upto 20%; hemorrhage rare 
• Hydrocephalus common (95%) 
CECT 
• >90% enhance 
• Relatively homogeneous 
MR Findings 
• T1WI: Hypointense to gray matter (GM) 
• T2WI: Near GM intensity 
• Flair: Hyperintense to brain 
• DWI: Restricted diffusion + 
• T1 C+ 
• >90% enhance 
• Often heterogeneous 
16. SCHWANNOMA 
CT Findings 
NECT 
• Cranial nerve schwannoma 
• Noncalcified extra-axial mass 
• Iso/slightly hyperdense compared to brain  
• May enlarge bony foramina (IAC, foramen ovale, facial nerve 
canal) 
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CECT: Strong, uniform enhancement 
MR Findings  
• T1W1: Usually iso-, sometimes mixed iso-/hypointense 
• T2WI: Hyperintense (nodule may be isointense) 
• DWI: Solid portion of schwannomas shows no restriction 
• T1 C+ 
• Enhances strongly 
• Cranial nerve schwannoma: 2/3 solid; 2/3 ring or 
inhomogeneous. 
17. PITUITARY MACROADENOMA 
CT Findings 
NECT 
• Variable attenuation 
• Typical - usually isodense with gray matter GM 
• Cyst formation , necrosis common 
• Hemorrhage 10% ; Ca++ 1-2% 
• Large Adenomas expand sella, may erode floor  
• Aggressive adenomas extend inferiorly  invade sphenoid, 
• May destroy upper clivus 
CECT :   Moderate , some what inhomogenous enhancement  
MR Findings 
T1WI  :         
¾ Usually isointense with GM  
¾ subacute hemorrhage has short T1  
42 
¾ Fluid-fluid levels may occur especially with pituitary apoplexy 
¾ PPBS absent in 20 % of large adenomas 
¾ Cavernous sinus invasion difficult to determine                                                
(medial wall is thin, weak ) 
T2WI:   
• Most common - isointense with gray matter  
• Less common 
• Cysts – hyperintense, hemorrhage  
• Dense granulated GH producing adenomas are often 
hypointense 
• Uncommon – High signal along optic tracts  
• FLAIR :Hyper intense to brain gray matter  
• T1 C+  : Enhances well 
• MRA   : ICA s often displaced, encased rarely occluded. 
18. CRANIO PHARYNGIOMA: 
CT Findings 
NECT  
• Adamantinomatous type 90%, mixed solid (iso), cystic 
(hypodense) 
• 90% calcify 
CECT:    90 % ENHANCE  
MR Findings 
• T1 WI :   
¾ Adamantinous type - hyperintense  
¾ Papillary type - isointense 
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• T2WI :  
¾ Cyst – hyper intense 
¾ Solid –  Hetero intense 
• FLAIR : Cyst- Hyperintense 
• DWI :  Variable 
• T1C+: Cyst walls Enhance , solid portions – Heterogenous 
Enhancement 
19. MENINGIOMAS: 
CT Findings 
NECT:  
• Hyperdense 75 % 
• Calcification 20% - 25% 
• Necrosis rare 
• Hyper ostosis and irregular cortex +  
CECT :  
• More than 90% Enhance homogenously and intensely 
MR Findings 
• T1 WI : Iso to hypo with GM 
• T2WI : Variable 
¾ Best to visualize CSF cleft 
• DWI :   Variable 
• T1 C+: More than 95% Enhance homogenously and intensely 
• Dural tail   35%- 80% of the cases(non specific) 
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20. ARACHNOID CYST:  
CT Findings 
NECT:    CSF density 
CECT :   No enhancement  
MR Findings 
• T1 WI    :  Isointense to CSF 
• T2 WI   :  Isointense To CSF 
• FLAIR  :  Suppresses completely 
• DWI    :   No restriction 
• T1C+   :   No enhancement 
21. EPIDERMOID CYST : 
CT  Findings 
 NECT:   
• CSF density 
• 10%-25% Calcification + 
CECT:   May show cyst margin enhancement 
MR Findings 
• T1WI    :   Slightly hyperintense to CSF 
• T2 WI  :   Iso intense To CSF 
• FLAIR :   Not Suppressed completely 
• DWI    :   Restricted diffusion + 
• T1C+   :   May show cyst margin enhancement (35%)  
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22. BRAIN STEM GLIOMA: 
• Classic Imaging apperance varies with tumour type and location  
• TECTAL: Pilocytic, focal, variable enhancement, ca++ 
• FOCAL TEGMENTAL MESENCEPHALIC:   Pilocytic, cyst + 
nodule 
• DIFFUSE PONTINE GLIOMA:  Fibrillary, diffuse, non 
enhancing. 
Incidence: 
Incidence of intracranial tumours in Indian series by 
Dr.B.Ramamurthy 1978 to 199417. 
S.NO TUMOURS PERCENTAGE 
1 Gliomas 42.09% 
2 Meningiomas 15.09% 
3 Pituitary tumours 15.15% 
4 Schwannoma 8.99% 
5 Metastasis 6.21% 
6 Vasoformative tumours 3.37% 
7 Developmental tumours 6.42% 
8 Lymphoreticulosis 0.58% 
9 Skull tumours 0.32% 
10 Sarcomas  0.85% 
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MATERIALS AND METHODS 
The study comprised of 80 patients including 41 males and 39 
females age ranging from    1    year  to   65  years. The study was 
conducted for a period of 18 months from March 2005 to august 2006. 
The patients were referred from Institute of Neurology, Government 
General Hospital, Chennai, Institute of Child Health, Egmore, Chennai-8 to 
Barnard Institute of  Radiology for radiological evaluation. 
Clinically  the most frequent symptom was head ache. Predominant 
clinical features were seizure, focal neurological deficit, cranial nerve palsies 
and loss of consciousness. 
Inclusion Criteria: 
All the patients who had radiological features suggestive of primary 
brain tumour.  
Exclusion Criteria: 
1) Patients who had already been worked up elsewhere and 
referred here with tissue diagnosis. 
2) Patients with known primary tumor elsewhere in the body with 
features of metastases to brain. 
3) Patients who were contraindicated for magnetic resonance 
imaging (Pace Makers, Claustrophobia). 
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COMPUTED TOMOGRAPHY: 
CT was done with TOSHIBA X SPEED Third Generation Scanner 
Machine Parameters:         
Tube Voltage     :  120 kv  
Tube Current    :  80 mA 
Scanning time   :  4 sec 
Filter         :  FC 20          
TECHNIQUE OF THE STUDY: 
Axial study was performed in all the cases and coronal study was 
performed    in relevant cases especially tumours of sella. 
Axial study done with following parameters: 
Patient position:  Supine with closed Eyes 
Slice Thickness :  10 mm 
Slice Interval    :   10 mm (for supratentorial) 
     5mm (for infra tentorial) 
  Plane of Section:   Osteo-Meatal  Line 
  Extent of Study:  From Base of the Skull to the High parietal region                   
Protocol For Coronal study: 
Patient position:  Prone with extended neck and closed Eyes 
 Slice Thickness :  5 mm 
 Slice Interval    :   5 mm  
 Plane of Section:  Perpendicular to the Hard palate 
48 
 Extent Of Study:   In the  region  of interest 
2mm thin sections were carried out in both axial and coronal studies 
in the region of interest for better spatial resolution. 
Contrast Study was performed in all cases and injected as rapid 
bolus. Quantity of the contrast media: 60 ml of Iohexol in rapid bolus.     
MRI TECHNIQUES 
MRI was performed using 1.5 Tesla superconducting SIEMENS 
MAGNETOM, symphony using head coil.  
POSITION: Patient is placed in supine position in the MRI gantry 
with head coil positioned. 
MRI TECHNIQUES USED: 
Multiplanar scout sections were obtained for planning sequences. 
Imaging of whole brain MR from vertex to foramen magnum including base 
of skull using axial, coronal and saggital sections with the following 
sequences was done.  
T1WI      T2WI 
TR: 500 msec  S/G – 5 / 1.5  TR: 4000 msec  S/G – 5 / 1.5 
TE: 14 msec     TE: 93msec 
FLAIR      DWI 
TR: 9000 msec  S/G – 5 / 1.5  TR: 4300 msec  S/G – 5 / 1.5 
TE: 105msec    TE: 123msec 
      b  : 0,500,1000 
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MRA 3D TOF    MRV 2D T0F 
TR: 839 msec  S/G – 5 / 1.5  TR: 30 msec  S/G – 5 / 1.5 
TE: 6.8 msec    TE : 6.5 msec 
GRE T2 Axial 
TR: 839 msec  S/G – 5 / 1.5 
TE: 27msec 
Contrast study  
It was performed in all cases – axial, sagittal, coronal sections using 
T1WI were taken. 
Quantity of contrast:  0.1 mmol/kg of dimeglumine Gadopentitate. 
For interpretation the following aspects of brain tumours were 
studied and analysed in these patients.  
1.  Location 
2. Margins 
• Ill defined margins 
• Moderately defined margins  
• Well defined margins     
3. CT Characteristics 
• Density 
• Calcification  
• Hemorrhage  
50 
• Mass effect  
• Contrast enhancement  
4. MRI Characteristics 
• T1 Signal intensity 
• T2 Signal intensity 
• FLAIR 
• Diffusion  
• Mass Effect 
• Contrast Enhancement 
The contribution of CT and MR towards the above mentioned 
aspects were analysed for arriving  the radiological diagnosis. 
Tissue biopsy and surgical exploration with tissue diagnosis were 
considered to confirm the diagnosis. 
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RESULTS AND ANALYSIS 
TABLE – 1:  
DISTRIBUTION OF PRIMARY BRAIN TUMOURS 
S.NO TUMOURS NO OF CASES 
1 Gliomas 42 
2 Meningiomas 11 
3 Sellar & Supra Sellar lesions 7 
4 Medulloblastoma 7 
5 Schwannoma 5 
6 Arachnoid cyst 2 
7 Epidermoid cyst 2 
8 Intraventricular tumours 4 
   
52%
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Meningiomas
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Sellar lesions
Medulloblastoma
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Arachnoid cyst
Epidermoid cyst
Intraventricular
tumours
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TABLE – 2 
SEX DISTRIBUTION 
sex S.NO 
TUMOURS 
No of 
cases 
Male % Female % 
1 Gliomas 42 25 59.5 17 40.5 
2 Meningiomas 11 3 27.2 8 72.8 
3 Sellar & Supra Sellar 
lesions 
7 4 57.1 3 42.9 
4 Medulloblastoma 7 4 57.1 3 42.9 
5 Schwannoma 5 2 40 3 60 
6 Arachnoid cyst 2 0 0 2 100 
7 Epidermoid cyst 2 1 50 1 50 
8 Intraventricular 
tumours 
4 2 50 2 50 
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TABLE - 3 
AGE DISTRIBUTION 
Age Glioma 
Menin-
gioma 
SELLAR 
Medullo 
Blastoma 
Schwa-
nnoma 
Arach 
cyst 
Epiderm 
cyst 
Intra 
ventricular 
0-10 1 – 3 3 – 2 – 1 
11-20 5 – 1 4 1 – – 1 
21-30 5 2 3 – – – – 2 
31-40 7 1 – – 3 – 1 – 
41-50 13 4 – – – – 1 – 
51-60 8 3 – – 1 – – – 
61-70 3 1 – – – – – – 
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TABLE -4 
DISTRIBUTION OF SUB TYPES OF GLIOMAS 
DISTRIBUTION OF SUBTYPES OF 
GLIOMAS
LA 19.5%
AA 26.6%
  Circ A 9%ODG 4%
GBM 40.9%
 
Out of 42 patients of gliomas, 17 patients (40.9%) were GBM, 11 
patients (26.6%) were anaplastic astrocytoma. 
S.No SUB TYPES No of cases PERCENTAGE 
1 Low grade astrocytoma 8 19.5% 
2 Anaplastic astrocytoma 11 26.6% 
3 Glioblastoma Multiforme 17 40.9% 
4 Circumscribed Astrocytomas 4 9% 
5 Oligodendroglioma 2 4% 
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TABLE – 5 
DISTRIBUTION OF PRIMARY BRAIN TUMOURS BY LOCATION 
 
 Distribution No of cases Percentage 
1. Supratentorial 59 73.7% 
2. Infratentorial 21 26.3% 
 Total 80 - 
Most of the primary brain tumours are located supratentorially. 
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TABLE – 6 
 
  Intraaxial % Extra 
axial 
% Total 
1. Supratentorial 37 62.7% 22 37.3% 59 
2. Infratentorial 12 57.1% 9 42.9% 21 
Infratentorially the occcurance of extra axial lesion are more 
common than supra tentorial location(table 5). 
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TABLE  - 7 
INTRAVENTRICULAR TUMOURS 
Site No of cases % 
Body of the lateral ventricles 2 50% 
Atrium 1 25% 
Foramen of Monro 1 25% 
Lateral ventricular tumours were the commonest location for intra 
ventricular tumours. 
TABLE – 8 
Calcification             
Hemorrhage 
 
S.No 
 
                            
Tumour 
Total 
Cases 
No of cases % No of 
cases 
% 
1 Glioma 42 5 11.9% 9 21.4%
2 Meningioma 11 3 27.2% 0 - 
3 Sellar 7 3 42.8% 0 - 
4 Medulloblastoma 7 2 28.5% 0 - 
5 Schwannoma 5 0 - 0 - 
6 Arachnoid Cyst 2 0 - 0 - 
7 Epidermoid cyst 2 0 - 0 - 
8 Intraventricular 
 tumours 
4 1 25% 0 - 
Calcification was noted  in 14 cases, out of 80 cases of primary brain 
tumours. 
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In glioma of 42 cases only 5 (11.9%) showed calcification. In 
meningiomas of 11 cases ,3 (27.2%)  showed calcification. All 3 cases of 
craniopharyngioma showed calcification. 
Hemorrhage was seen in 9 cases all were proved to be glioblastoma 
in HPE. 
TABLE – 9 
MRI SIGNAL CHARACTERISTICS OF TUMOURS 
SEQUENCE HYPO HYPER ISO HET 
T1 WI 51 1 4 24 
T2 WI 3 37 7 33 
Most tumours were hypointense on T1WI and hyperintense on T2 WI. 
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TABLE – 10 
CONTRASTENHANCEMENT OF THE GLIOMAS 
 
NO CE ENHANCEMENT 
GLIOMAS TOTAL No of 
cases % 
MILD 
CE 
MOD 
CE INTENSE % 
LA 8 8 100% - - - - 
AA 11 6 54.5% 3 2 - 45.5%
GBM 17 - - - 8 9 100%
CIRC A 4 - - 2 2 0 100%
ODG 2 - - 2 - - 100%
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Low grade astrocytoma- No enhancement noted  
Mild to moderate enhancement noted in 5 cases(45.5%) of AA. 
Moderate to intense enhancement  noted in 17 cases (100%) of 
GBM. 
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TABLE – 11 
MENINGIOMA IN T2WI SEQUENCES 
T2 NO OF CASES PERCENTAGE 
ISO 6 55% 
HYPO 1 9% 
HYPER 2 18% 
HET 2 18% 
 
MENINGIOMA IN T2WI IMAGE 
SEQUENCES 
(No of cases)
2
2
1
6
ISO
HYPO
HYPER
HET
 
64% of  meningiomas were iso to hypointense on T2WI.two cases 
were hyperintense on T2WI  which were histologically turned out to be 
meningothelial type. 
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TABLE – 12 
DIFFUSION RESTRICTION OF TUMOURS 
Diffusion restriction noted in epidermiod cysts 100% , 
medulloblatomas 42.8%.  
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     NO  RESTRICTION RESTRICTION  
TUMOURS 
TOTAL 
NO OF 
CASES CASES % CASES % 
GLIOMA 42 42 100% - - 
MENINGIOMA 11 11 100% - - 
SELLAR LESIONS 7 7 100% - - 
MEDULLOBLATOMA 7 4 57% 3 43% 
SCHWANNOMA 5 5 100% - - 
ARACHNOID CYST 2 2 100% - - 
EPIDERMOID CYST 2 0 - 2 100% 
INTRAVENTRICULAR 
TUMOURS 
4 4 100% - - 
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DISCUSSION 
In our study of 80 patients, 52.5%  were gliomas. Out of 42 cases of 
gliomas, 17 cases were glioblastoma multiforme ,11 anaplastic astrocytoma, 
8 low grade astrocytoma, 4circumscribed astrocytoma, 2 were 
oligodendroglioma. The peak incidence of these tumours were 5th and 6th 
decade and male to female ratio is 1.47:1.  
The incidence, peak age of presentation are comparable to De Jongh 
et al., 1978 and Silverman et al in 198118. 
In our study of 17 cases of glioblastoma multiforme, all were 
heterointense on T1WI due to hemorrhage and necrosis. CT and MRI  
diagnosis was  made in 15 cases of glioblastoma multiforme and other two 
appeared as anaplastic astrocytoma which were glioblastoma multiforme  
on HPE.  
Of 11 cases of anaplastic astrocytoma, 1 case radiologically 
appeared as glioblastoma multiforme. 
On contrast administration, no enhancement was noted in low grade 
astrocytomas. Enhancement was noted in 45.5% of anaplastic astrocytoma, 
100% of glioblastoma multiforme. There  is  relationship of contrast 
enhancement and tumour grading noted in our study. All glioblastoma 
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multiforme cases showed intense enhancement of tumour margins (non 
necrotic areas). 
This is comparable to the results of Earnest F IV, Scheithauer  BW  et 
al., in  year 2000, in which the intensity of the enhancement is significant 
and correlates with the level of cellular anaplasia19. 
Hemorrhage was noted in 9 cases of 42 gliomas and all were 
glioblastoma multiforme.  
So grading of malignancy using CT and MRI  is 92%. Study of  Dean 
B, Drayer B, Bird C et al in 1990 showed that the imaging features on CT 
& MRI, although generally correlating with tumour grade, are not entirely 
specific20. 
Calcification was noted  in 14 cases out of 80 cases of primary brain 
tumours. In glioma of 42 cases only 5 (11.9%) showed calcification. In 
meningiomas of 11 cases, 3 (27.2%)  showed calcification. All 3 cases of 
craniopharyngioma showed calcification. 
Dense calcification noted in oligodendroglioma, mural nodule 
calcification was noted in pilocytic astrocytoma. 
In three cases of craniopharyngioma all showed calcification in the 
solid component. One  of two cases of central neurocytoma showed  
calcification. 
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LOW GRADE ASTROCYTOMA: 
Incidence of low grade astrocytoma in our study was 10% of primary 
brain tumours.  
Most cases displayed no mass effect, no calcification, no 
hemorrhage. No contrast enhancement noted. 
Smirniotopoulus JG et al 1n 1999 showed that in low grade 
astrocytoma the contrast enhancement is usually absent reflecting a lack of 
tumour vascularity, blood brain barrier break down, or both. The above 
character is also noted in our study21.   
All lesions appeared hypointense on T1, most appeared hyperintense 
onT2 and showed no diffusion restriction. There was one false negative 
case in which radiologically appeared granulomatous lesion turned out to 
be low grade astrocytoma on HPE. Hence the sensitivity is 87.5% in 
diagnosing low grade astrocytoma by CT & MRI. 
ANAPLASTIC ASTROCYTOMA: 
Incidence of anaplastic astrocytoma in our study was 13.7% of 
primary brain tumours.  
Peak  age of incidence –4th and 5th decade. 
Male: female ratio  1.2:1. 
In our study anaplastic astrocytomas were ill defined, exhibited 
moderate mass effect. 
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Contrast enhancement noted in 5 cases. Calcification and 
hemorrhage were not seen. In MRI most lesion appear hetero intense on    
T2 WI. Out of 11 cases of anaplastic astrocytoma, 10 cases identified as 
anaplastic astrocytoma radiologically  and  one case reported  as 
glioblastoma multiforme. Hence the sensitivity of CT & MRI in diagnosing 
AA is 90.9%. 
GLIOBLASTOMA MULTIFORME: 
Incidence of glioblastoma multiforme in our study  was 21.2% of 
primary brain tumours. 
Male: female ratio  1.4:1.  
Peak  age of incidence –5th and 6th decade 
All the glioblastoma multiforme were ill defined in CT, exhibited 
more mass effect and heterogeneity and more vasogenic oedema. All 
showed areas of necrosis and hemorrhage which were clearly demonstrated 
on MRI. Calcification was noted in 1 case. Contrast enhancement was  
noted in all cases in non necrotic areas which was moderate to intense. 
Butler AR, Horri SC et al., in their study showed that that contrast 
enhancement of viable tumour including the peripheral rim and the 
intratumoral solid portions is nearly universal in glioblastomas22. Our study 
also revealed the same feature. 
 Out of 17 cases of glioblastoma multiforme, 15 cases were 
diagnosed as glioblastoma multiforme and 2 cases  were diagnosed as 
anaplastic astrocytoma. So, the sensitivity is 88.2% in diagnosing GBM. 
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OLIGODENDROGLIOMA:  
Incidence of oligodendroglioma in our study is 2%.  
Both the cases were hyperdense on plain CT with dense calcification 
and mild contrast enhancement and oedema. On MRI both the lesions were 
hetero intense on T1WI  and T2 WI due to calcification. The diagnostic 
accuracy of oligodendroglioma in our study is 100%.  
MENINGIOMAS: 
They are the most common nonglial primary brain tumour. Most are 
homogeniusly hyperdense and densely enhances on contrast 
administration. According to Aronove et al ., in 1978 CT detects 85%  and 
95 % of cases in plain and contrast enhanced CT respectively.   
Incidence of meningiomas in our study  was 13.7% of primary brain 
tumours. 
Male: female ratio 0.3 : 1   showing female predominance.  
Peak  age of incidence--5th and 6th decade. 
Distribution of meningioma in our study : 
 Falx and convexity  --7 cases (64%) 
 Supra sellar             -- 2 cases  
 CP angle             -- 2 cases  
Naidich TP et al in 1990 in their study showed that the parasaggital 
region and the cerebral convexity are the common sites accounting for 
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nearly half of all meningiomas23.  This same distribution pattern was seen in 
our study. 
On plain CT 10 cases were homogenously hyperdense and one was 
isodense. Calcification noted in three cases 27.2 % and in CECT dense 
homogenous enhancement noted in all the cases. Dural tail was noted in 4 
cases (36.3%). 
Out of 11 cases of meniongima, correct diagnosis was made out in 
10 cases, one was diagnosed radiologically as schwannoma which 
histologically turned out as meningioma. On MRI T2 WI most meningiomas 
appeared as iso to hypointense to the gray matter. Two cases appeared as  
hyperintense on T2WI  which were meningothelial type of meningiomas on 
HPE. This is comparable with the study of Kaplan RD , Drayer BP et al., in 
year 1992 and Zee CS, Chin T et al in 1992 in which meningiomas with T2 
hyperintensity are of meningothelial type24,25,26. 
CIRCUMSCRIBED ASTROCYTOMA: 
All the cases in our study were pilocytic astrocytomas, two were 
supratentorial and two were infratentorial in location. All showed large 
cystic component and a mural nodule. And two cases showed calcification 
of the mural nodule. All cases showed mural nodule enhancement as per 
the following study. 
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Luh GY, Bird CR et al in 1999 showed that typically after 
intravenous administration of contrast agent dense homogenous 
enhancement of tumour nodule but not of the other walls of the cyst27. 
MEDULLOBLASTOMA: 
In our study there were 7 cases of medulloblastoma out of 80 cases 
of primary brain tumours. The incidence was 8.7%. Most appeared 
hyperdense on plain  CT and showed moderate contrast enhancement. 
They appeared hypointense on T1WI and hyperintense on T2WI and 
FLAIR. Three cases out of 7 showed diffusion restriction.  
This is comparable to the study of Rodallec M,Colombat M et al.,  
in 2004 in which 2 cases  showed diffusion restriction suggestive of small 
cell histology28,29. 
ACOUSTIC SCHWANNOMA: 
In our study, 5 cases  were acoustic schwannomas which showed 
acute angulation with the petrous ridge. and  the incidence was 6%. Most of 
them isodense to the cortex on CT and all showed contrast enhancement. 
Most were hyopointense onT1WI and hyperintense on T2WI and FLAIR 
and showed  no diffusion restriction. 
TUMOURS OF SELLAR AND SUPRA SELLAR REGIONS: 
Pituitary adenomas are the common lesions in the sella accounting 
for 10 % of all primary neoplasms as reported by Russel and Rubinstein et 
al., in 1989. In our study of  80 cases 4 cases were pituitary macro adenomas 
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and three were craniopharyngiomas. All the pituitary macraoadenomas 
enhanced well with contrast. And one showed carotid encasement. Most 
appeared hypointense on T1WI , slightly hyperintense on T2WI. 
Incidence of craniopharyngioma in our study is 42% of sellar lesions. 
All occurred in children and all showed calcification. All showed 
heterointense signal in T1WI and T2WI  due to cystic areas and 
calcification. All showed mild to moderate contrast enhancement (100%).  
Johnsen DE Woodruff WW, Allen IS et al showed that of all the sellar 
region masses, craniopharyngiomas have the most heterogenous MR 
imaging spectrum30,31. 
ARACHNOID CYST: 
Two cases were arachnoid cyst one in posterior fossa and the 
another was in right middle cranial fossa. Both of them followed CSF signal 
intensity in all pulse sequences and showed no diffusion restriction. 
EPIDERMOID CYST: 
There were two cases of epidermoid cysts in our study. One was 
located in the left cerebello pontine angle and another was in middle 
cranial fossa. Both the lesions appeared hypodense on CT. On MRI they 
appeared hypointense on T1WI and hyperintense on T2WI. Both the 
lesions were not suppressed on FLAIR and they showed diffusion 
restriction. There was no contrast enhancement in both the cases32. 
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INTRAVENTRICULAR TUMOURS: 
There were 4 cases of intraventricular tumours in our study. The 
incidence was 5%. Two cases located in the body of the lateral ventricle 
and both were central neurocytomas. Both the lesions appeared 
heterodense with lobulated ‘bubbly’ appearance. One showed calcification. 
There was mild contrast enhancement. On MRI they appeared 
heterointense and showed attachment to the septum pellucidum and mild 
contrast enhancement. 
 One case was choroid plexus papilloma situated in the atrium of the 
right lateral ventricle which was lobulated and isodense on CT. On MRI the 
lesion appeared isointense on T1WI & T2WI. On contrast there was intense 
contrast enhancement. There was communicating hydrocephalus clearly 
demonstrated by both CT & MRI.  
Shoemaker EI, Gado M et al study showed that intense slightly 
heterogenous enhancement following contrast administration is seen in 
virtually in all choroid plexus papillomas33. 
Colloid cyst at the foramen of monro was well defined and 
hyperdense on plain CT. The lesion was hyperintense on T1WI  and 
hypointense on T2WI. There was no contrast enhancement. 
71 
CONCLUSION 
Computed tomography and magnetic resonance imaging are 
excellent modalities in diagnosis of primary brain tumours especially in 
tumour location and extent. 
In majority of the cases, it is  possible to arrive at a specific diagnosis 
based on CT & MRI characteristics. 
With these modalities we can also guide the neurosurgeons to the 
ideal site of biopsy and to support in deciding the nature of therapy. 
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ANNEXURE 
ABBREVIATION 
AA – Anaplastic Astrocytoma 
CT – Computed Tomography 
CECT – Contrast Enhanced Computed Tomography 
Ca++ – Calcification 
Circ A – Circumscribed Astrocytoma 
DWI – Diffusion Weighted Imaging 
FLAIR – Fluid  attenuation and Inversion Recovery Sequence 
GBM – Glioblastoma multiforme 
HPE – Histopathological examination 
LA – Low Grade Astrocytoma 
MRI – Magnetic Resonance Imaging 
MRA – MR - Angiography 
MRV – MR - Venography 
MRS – Magnetic Resonance Spectroscopy 
NECT – Nonenhanced Computed Tomography 
ODG – Oligodendro Glioma 
T1WI – T1 weighted imaging 
T2WI – T2 weighted imaging 
T1C+ – T1 contrast 
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PROFORMA 
IMAGING OF PRIMARY BRAIN TUMORS 
NAME: 
 
AGE: 
 
SEX: 
 
WARD:                       UNIT:                        IP NO: 
 
COMPLAINTS: 
                
 Headache 
 Projectile vomiting 
 Neurological defecit 
 Seizures 
 
CLINICAL EXAMINATION: 
 Motor system 
 Sensory system 
 Cerebellar system 
 Fundus – papillodema  
             
INVESTIGATIONS 
 CT 
           MRI 
          RADIOLOGICAL DIAGNOSIS 
HPE  DIAGNOSIS 
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MASTER CHART 
CT MRI 
S. 
No 
Name Age/Sex Location 
Margin Density Calcific HE Edema mass Cont. T1 T2 FLAIR Diff 
 
Edema 
Mass 
Cont. 
Radiologic 
Diagnosis 
HPE 
1. Ravi 35/M Rt.Temporal MD Hypo – – – – Hypo Hyper Het – – – LA DA G II 
2. Srinivasalu 8/M Pons ID Hypo – – + – Hypo Hyper Het – + – LA DA G II 
3. Govindasamy 48/M Rt.Temporal ID Hypo – – – – Hypo Hyper Hyper – – – LA DA G II 
4. Gajendry 52/F Lt. parietal MD Hypo – – – – Hypo Hyper Hypo – – – LA DA G II 
5. Saravanan 19/M Rt. parietal MD Hypo – – – – 
 
Hypo Hyper Hyper – – – LA DA G II 
6. Ramalingam 24/M Pons MD Hypo – – + – Hypo Hyper Hyper – + – LA DA G II 
7. Kannan 20/M Lt. parietal ID Hypo – – – – Hypo Hyper Hyper – + – Tuberculoma DA G II 
8. Hemavathy 37/F Rt. Frontal ID Hypo – – – – Hypo Hyper Hyper – + – L.A DA G II 
9. Kumar 32/M Rt. TP ID Hypo – – + + Hypo Het Het – + + AA DA G III 
10. Thirunavokarasu 47/M Lt. P MD Hypo – – + + Hypo Hyper ISO – + ++ AA DA G III 
11. Pandian 27/M Rt. P MD Hypo – + – + Het Hyper Het – + ++ AA DA G III 
12. Kanniappan 65/M Lt. 
Temporal 
ID Het – – + + Hypo Hyper Hyper – + + AA DA G III 
13. Subalakshmi 53/F Rt.Frontal ID Hypo – – + + Hypo Het Het – + + GBM DA G III 
14. Sivaji 50/M Lt. FP ID Hypo – – + – Hypo Hyper Hyper – + – AA DA G III 
15. Gopala Krishnan 45/M Lt. PO ID Hypo – + + – Hypo Hyper Hyper – + – AA DA G III 
16. Sarasu 35/F Rt. parietal ID Hypo – – + – Hypo Het Het – + – AA DA G III 
17. Uma 36/F Lt. Parietal ID Hypo – – + – Hypo Het Het – + – AA DA G III 
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CT MRI 
S. 
No 
Name Age/Sex Location 
Margin Density Calcific HE Edema mass Cont. T1 T2 FLAIR Diff 
 
Edema 
Mass 
Cont. 
Radiologic 
Diagnosis 
HPE 
18. Fahima 45/F Rt.Temporal ID Hypo – – + – Hypo Het Het – + – AA DA G III 
19. Kanniammal 46/F Lt.Temporal ID Hypo – – + – Hypo Het Het – + – AA DA G III 
20. Raja 25/M Rt. Frontal ID Het – + + + Hypo Het Het – + ++ GBM DA G IV 
21. Sujatha 36/F Bifrontal ID Het – + + ++ Hypo Het Het – + ++ GBM DA G IV 
22. Chandramouli 18/M Bifrontal ID Hypo – + + ++ Hypo Hyper Hyper – + ++ GBM DA G IV 
23. Pandi 42/M Lt. Frontal ID Hypo + – + +++ Het Het Het – + +++ GBM DA G IV 
24. Amudha 43/F Bifrontal ID Hypo – – + ++ Het Het Het – + ++ GBM DA G IV 
25. Ramasamy 46/M Lt. Parietal ID Hypo – + + +++ Het Het Het – + +++ GBM DA G IV 
26. Fathima 48/F Rt. Parietal ID Hypo – – + ++ Het Het Het – + ++ GBM DA G IV 
27. Abdul 42/M Lt. emporal ID Hypo – – + +++ Het Het Het – + +++ GBM DA G IV 
28. Victoria 43/F Rt.Temporal ID Hypo – + + ++ Het Het Het – + ++ GBM DA G IV 
           
29. Christopher 51/M Lt. Occipital ID Hypo – – + +++ Het Het Het – + +++ GBM DA G IV 
30. Malathy 52/F Rt. Frontal ID Hypo – + + + Het Het Het – + + AA DA G IV 
31. John 53/M Bifrontal ID Hypo – + + +++ Het Het Het – + +++ GBM DA G IV 
32. Chithirai 53/F Bifrontal ID Hypo – – + ++ Het Het Het – + +++ GBM DA G IV 
33. Malarkannan 55/M Lt. Frontal ID Hypo – – + +++ Het Het Het – + +++ GBM DA G IV 
34. Ramalakshmi 56/F Lt. Parietal ID Hypo – – + ++ Het Het Het – + +++ GBM DA G IV 
35. Palani 62/M Rt. Parietal ID Hypo – – + +++ Het Het Het – + +++ GBM DA G IV 
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CT MRI 
S. 
No 
Name Age/Sex Location 
Margin Density Calcific HE Edema mass Cont. T1 T2 FLAIR Diff 
 
Edema 
Mass 
Cont. 
Radiologic 
Diagnosis 
HPE 
36. Arumugam 65/M Rt. 
Temporal 
ID Hypo – – + + Het Het Het – + + AA DA G IV 
37. Sridhar 13/M Lt. Parietal MD Hypo with 
Isodense 
nodule 
– – + + 
mural 
Hypo Hyper Hyper – + + 
Mural 
Nodule 
PilocyticAstro PilocyticAstro 
38. Prabhakaran 29/M PF MD Hypo – – + + Hypo Hyper – – + ++ Pilocytic 
Astro 
PilocyticAstro 
39. Chitra 22/F Rt. Parietal MD Hypo + – + + Hypo Hyper Hypo – + + PilocyticAstro PilocyticAstro 
40. Selvi 12/F PF MD Hypo + – + + Hypo Hyper Hypo – + ++ PilocyticAstro PilocyticAstro 
41. Murugan 36/M Rt. Frontal MD Hyper ++ – + + Het Het Het – + + ODG ODG 
42. Nallal 44/F Lt. Frontal MD Hyper ++ – + + Het Het Het – + + ODG ODG 
43. Vasanthi 45/F Lt. CP 
angle 
MD Hyper + – – ++ Hypo ISO ISO – + ++ Meningioma  Meningioma 
44. Maheswari 26/F Rt. Frontal 
convexity 
MD ISO – – + ++ Hypo ISO ISO – + ++ Meningioma Meningioma 
45. Muthusamy 52/M High 
Parietal 
WD Hyper – – + ++ Hypo ISO ISO – + ++ Meningioma Meningioma 
46. Dhanavalli 37/F Suprasellar MD Hyper – – – ++ ISO ISO Hyper – – ++ Meningioma Meningioma 
47. Vijaya 23/F Convexity 
Lt. Parietal 
MD Hyper ++ – + + Het Het Het – + + Calcified 
Meningioma 
Meningioma 
48. Ramprasath 42/M Rt. CP 
Angle 
MD Hyper – – + ++ ISO  ISO ISO – + ++ Schwannoma Meningioma 
49. Alagu Selvam 52/M Rt. Parietal 
Convexity 
MD Hyper + – – +++ Het Het Het – + +++ Meningioma Meningioma 
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CT MRI 
S. 
No 
Name Age/Sex Location 
Margin Density Calcific HE Edema mass Cont. T1 T2 FLAIR Diff 
 
Edema 
Mass 
Cont. 
Radiologic 
Diagnosis 
HPE 
50. Banu 62/F Falx WD Hyper – – – ++ Hypo Hypo Hypo – + +++ Meningioma Meningioma 
51. Chitra 43/F Falx WD Hyper – – + ++ Hypo ISO ISO – + +++ Menigioma Menigioma 
52. Durga 48/F Suprasellar WD Hyper – – + ++ Hypo Hyper Hyper – + ++ Meningioma Menigioma 
53. Ellammal 57/F Falx WD Hyper – – + +++ Hypo Hyper Hyper – + +++ Meningioma Menigioma 
54. Tamilsevan 25/M Sella MD Hypo – – + +++ ISO ISO ISO – + +++ Pit. Macro 
adenoma 
Pit. Macro 
adenoma 
55. Subashkumar 20/M Sellar WD ISO – – – ++ Hypo Hyper Hyper – – ++ Pit. Macro 
adenoma 
Pit. Macro 
adenoma 
56. Lakshmi 30/F Sella MD Hypo – – – + Hypo Hyper Hyper – – + Pit. Macro 
adenoma 
Pit. Macro 
adenoma 
57. Kavitha 28/F Sella MD Hypo – – – + Hypo Hyper Hyper – – + Pit. Macro 
adenoma 
Pit. Macro 
adenoma 
58. Sugmaran 5/M Suprasellar  MD Het ++ – + + Het Het Het – + ++ Cranio 
Pharyngioma 
Cranio 
Pharyngioma 
59. Tamil Selvan 1/M SupraSellar WD Hypo + – – ++ Hypo Het Het – – ++ Cranio 
Pharyngioma 
Cranio 
Pharyngioma 
60. Sangeetha 4/F SupraSellar MD Het + – + + Het Het Het – +  
+ 
Cranio 
Pharyngioma 
Cranio 
Pharyngioma 
61. Siva 11/M PF 
 
ID Het + – + + Het Hyper Hyper + + ++ Medullo 
Blastoma 
Medullo 
Blastoma 
62. Purani 13/F PF MD Hyper – – + ++ Hypo Het Het + + ++ Medullo 
Blastoma 
Medullo 
Blastoma 
63. Preethikumari 12/F PF MD Hyper – – + ++ Hypo Hyper Hyper + + ++ Medullo 
Blastoma 
Medullo 
Blastoma 
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CT MRI 
S. 
No 
Name Age/Sex Location 
Margin Density Calcific HE Edema mass Cont. T1 T2 FLAIR Diff 
 
Edema 
Mass 
Cont. 
Radiologic 
Diagnosis 
HPE 
64. Palpandian 17/M Lt. 
cerebellar 
hemisph 
MD Het – – + + Hypo Hyper Hyper – + + Medullo 
blastoma 
Medullo 
Blastoma 
65. Rani 10/F PF ID Hyper + – + ++ Hypo Hyper Hyper – + ++ Medullo 
Blasma 
Medullo 
Blastoma 
66. Sankaran 6/M PF MD Hyper – – + ++ Hypo Hyper Hyper – + ++ Medullo 
Blasma 
Medullo 
Blastoma 
67. Balaji 8/M PF MD Hyper – – + ++ Hypo Hyper Hyper – + ++ Medullo 
Blastoma 
Medullo 
Blastoma 
68. Amudha 40/F Lt. CP 
angle 
MD ISO – – + ++ Het  Hyper Hyper – + ++ Acoustic 
Schvannoma 
Acoustic 
Schvannoma 
69. Devaki 51/F Lt. CP 
angle 
ID Hypo – – + + Hypo  Het Het – + + Acoustic 
schvannoma 
Acoustic 
Schvannoma 
70. Rani 35/F Rt. CP 
Angle 
MD ISO – – + ++ Hypo Hyper Hyper – + ++ Acoustic 
Schwannoma 
with multiple 
meningioma 
Acoustic 
Schwannoma 
71. Ramu 35/M Rt. CP 
angle 
MD Het – – + + Hypo Hyper Hyper – + + Acoustic 
Schwannoma 
Acoustic 
Schwannoma 
72. Suresh  19/M Lt. CP 
angle 
MD ISO – – + ++ Hypo Hyper Hyper – + ++ Acoustic 
Schwannoma 
Acoustic 
Schwannoma 
73. Reshma 9/F Rt. Middle 
Cranial 
Fossa 
WD Hypo – – – – Hypo Hyper Hypo – – – Arachnoid 
Cyst 
Arachnoid 
Cyst 
74. Ramya 1/F Post Fossa WD Hypo – – – – Hypo Hyper Hypo – – – Arachnoid 
Cyst 
Arachnoid 
Cyst 
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CT MRI 
S. 
No 
Name Age/Sex Location 
Margin Density Calcific HE Edema mass Cont. T1 T2 FLAIR Diff 
 
Edema 
Mass 
Cont. 
Radiologic 
Diagnosis 
HPE 
75. Srivasan 55/M Lt. CP 
angle 
MD Hypo – – + – Hypo Hyper Hyper + + – Epidermoid 
cyst 
Epidermoid 
cyst 
76. Muniyammal 40/F Suprasellar MD Hypo – – – – Hypo Hyper Hypo + – – Epidermoid 
cyst 
Epidermoid 
cyst 
77. Suresh 23/M Bodies lat 
ventricles 
MD Het – – – ++ Het Hyper Het – – ++ Central 
Neurocytoma 
Central 
Neurocytoma 
78. Sukumar 25/M Bodies of 
Lat. vent 
ID Hetero + – + + Hypo Het Het – + + Central 
Neurocytoma 
Central 
Neurocytoma 
79. Sangeetha 5/F Rt. Lat. 
Ventricle 
Atrium 
Lobulated ISO – – Hydro 
cephalus 
+++ ISO ISO ISO – Hydro 
Cephalus 
+++ Chroid Plexus 
Papilloma 
Chroid 
Plexus 
Papilloma 
80. Ramya 20/F Foramen oif 
Monro 
WD Hyper – – + – Hyper Hypo Hypo – + – Colloid Cyst Colloid Cyst 
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KEY TO THE MASTER CHART 
Location: 
Rt- Right, Lt- left, CP- Cerebellopontine angle, TP- Temporo parietal 
region, PF- Posterior fossa, 
 Margins:  
WD- well defined, MD- Moderately defined, ID- ill defined 
Density:  
Hypo – Hypodensity , Hyper – Hyperdensity, Het- heterodensity 
 ISO- Isodensity 
Cont – Contrast 
+ - Mild enhancement, ++ - Moderate enhancement, 
  +++ - Intense enhancement 
T1,T2, FLAIR :  
Hypo – Hypointensity, Hyper – Hyperintensity, Het- Heterointensity, Iso - 
isointensity. 
Diff – Diffusion weighted imaging 
Radiological diagnosis:  
LA   - Low grade astrocytoma 
AA  - Anaplastic astrocytoma 
Astro   - Astrocytoma  
GBM   - Glioblastoma Multiforme 
Pit       - Pituitary   
ODG   - Oligodendrglioma 
DAG   - Diffuse Astrocytoma Grade 
